Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
OpenClinica
Best for
Academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
What to consider
OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.
Sponsors and CROs of any size running multi-country trials who want a per-study license with unlimited users.
What to consider
Viedoc combines an Everest Group Leader rating with no-downtime study changes, strong certifications and a published pricing model. It has no native CTMS and no named eConsent module.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
OpenClinica vs Viedoc (EDC): category feature evidence and sources. Products are not ranked.
Category feature
OpenClinica
Viedoc
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
OpenClinica
Supported
OpenClinica says its technology has powered over 15,000 studies and more than three million patients.
eConsent, eCOA and randomization establish base support despite the stated absence of native supply and coding.
Viedoc
Extended support
Viedoc lists native randomization, trial supply management, medical coding and ePRO; consent is offered as remote consent rather than a named eConsent module, and there is no CTMS.